Intricate technical design of the Sniper Balloon Occlusion Microcatheter allows for easy navigation through small complex vascular structures providing enhanced reach to distal target sites.
Designing Performance. Delivering Precision.
Sniper Product Family
| Product Number | Working Length | Dead Space Volume | Tip | Outer Diameter | Inner Diameter | Balloon Diameter | Guidewire | Injection Pressure |
| SBC0629-STR-110 | 110 cm | 0.32 ml | Straight tip | Proximal 2.9F/0.038" Distal 2.2F/0.029" |
0.020"/0.5 mm | Up to 6 mm | 0.014" or 0.016" | Up to 900 psi |
| SBC0629-STR-130 | 130 cm | 0.36 ml | ||||||
| SBC0629-STR-150 | 150 cm | 0.41 ml | ||||||
| SBC0629-STR-165 | 165 cm | 0.45 ml | ||||||
| SBC0629-KTP-110 | 110 cm | 0.32 ml | K-tip | |||||
| SBC0629-KTP-130 | 130 cm | 0.36 ml | ||||||
| SBC0629-KTP-150 | 150 cm | 0.41 ml |
| Product Number | Working Length | Dead Space Volume | Tip | Outer Diameter |
| SBC0629-STR-110 | 110 cm | 0.32 ml | Straight tip | Proximal 2.9F/0.038" Distal 2.2F/0.029" |
| SBC0629-STR-130 | 130 cm | 0.36 ml | ||
| SBC0629-STR-150 | 150 cm | 0.41 ml | ||
| SBC0629-KTP-110 | 110 cm | 0.32 ml | K-tip | |
| SBC0629-KTP-130 | 130 cm | 0.36 ml | ||
| SBC0629-KTP-150 | 150 cm | 0.41 ml |
| Inner Diameter | Balloon Diameter | Guidewire | Injection Pressure |
| 0.020"/0.5 mm | Up to 6 mm | 0.014" or 0.016" | Up to 900 psi |
| Product Number | Working Length | Dead Space Volume |
| SBC0629-STR-110 | 110 cm | 0.32 ml |
| SBC0629-STR-130 | 130 cm | 0.36 ml |
| SBC0629-STR-150 | 150 cm | 0.41 ml |
| SBC0629-KTP-110 | 110 cm | 0.32 ml |
| SBC0629-KTP-130 | 130 cm | 0.36 ml |
| SBC0629-KTP-150 | 150 cm | 0.41 ml |
| Tip | Outer Diameter | Inner Diameter |
| Straight tip | Proximal 2.9F/0.038" Distal 2.2F/0.029" |
0.020"/0.5 mm |
| K-tip |
| Balloon Diameter | Guidewire | Injection Pressure |
| Up to 6 mm | 0.014" or 0.016" | Up to 900 psi |
Designed for arterial embolization procedures such as:
- Transarterial Embolization (TAE)
- Transarterial Chemoembolization (TACE)
- Radioembolization (Y-90)
- Arteriovenous Malformation (AVM)
- Prostate Artery Embolization (PAE)
- Gastrointestinal Bleeds
- Renal Angiomyolipoma (AML)
- Uterine Fibroid Embolization (UFE)
Designed for arterial embolization procedures such as:
- Transarterial Embolization (TAE)
- Transarterial Chemoembolization (TACE)
- Radioembolization (Y-90)
- Arteriovenous Malformation (AVM)
- Prostate Artery Embolization (PAE)
- Gastrointestinal Bleeds
- Renal Angiomyolipoma (AML)
- Uterine Fibroid Embolization (UFE)
Compatible with the delivery of *:
- Lipiodol®
- Glue (n-bCA)
- Coils up to 0.018″
- Gelfoam
- Spherical particles up to 900 μm
- Dimethyl Sulfoxide (DMSO)
- Ethanol (EtOH)
*See Sniper Chemical Compatibility Statement Letter MK-0351 below. Embolx does not make any claims; for information purposes only.
What is Pressure-Directed Embolization?
The Sniper’s balloon occludes the vessel to alter blood flow-dynamics using pressure-directed embolization. This increases therapeutic agent delivery into target areas while protecting surrounding healthy tissue. 1,2
- Rose S, Halstead G, Narsinh K. Pressure-Directed Embolization of Hepatic Arteries in a Porcine Model Using a Temporary Occlusion Balloon Microcatheter: Proof of Concept. Cardiovasc Intervent Radiol (2017) 40: 1769.
- Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89.
- Maruyama M, Yoshizako T, Nakamura T, et al. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol (2016) 39: 359-366.
- Irie T, Kuramochi M, Takahashi N. Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodules during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure. Cariovasc Intervent Radiol (2013) 36: 706-713.
- Ogawa M, Takayasu K, Hirayama M, et al. Efficacy of a microballoon catheter in transarterial chemoembolization using miriplatin, a lipophilic anticancer drug: short-term results. Hepatology Research (2016) 46: E60-69.
- Arai H, Abe T, Takayama H, et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatology Research (2015) 45: 663-666.
- Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatology Research (2016) 46: 209-214.
- Stephan Ogenstad, Statogen Consulting LLC. Meta-analysis of clinical studies performed by: Ogawa (2016) ref. 5, Arai (2015) ref. 6, and Irie (2016) ref. 7. Analysis on file at Embolx, Inc. (2017).
